- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on redOx Metabolism in Australia
Total 1694 results
-
SanofiTerminatedDiabetes Mellitus, Type 2Australia
-
Baker Heart Research InstituteNational Health and Medical Research Council, Australia; Hoffmann-La Roche; Diabetes...CompletedDiabetes Mellitus, Type 2Australia
-
Carmot Therapeutics, Inc.Carmot Australia First Pty LtdRecruiting
-
Arrowhead PharmaceuticalsCompletedDyslipidemias | Hypertriglyceridemia | Familial HypercholesterolemiaAustralia, New Zealand
-
Royal Adelaide HospitalCompletedDiabetes Mellitus | GastroparesisAustralia
-
NGM Biopharmaceuticals, IncNGM Biopharmaceuticals Australia Pty LtdCompleted
-
Bayside HealthUnknownSympathetic Activity in Individuals With the Metabolic Syndrome: Benefits of Lifestyle InterventionsMetabolic Syndrome XAustralia
-
University of AdelaideRoyal Adelaide HospitalCompletedInsulin Resistance | Diabetes Mellitus, Type IIAustralia
-
RDC Clinical Pty LtdNot yet recruiting
-
Barmherzige Brüder LinzCompletedSepsis | Inflammation | Lipid Metabolism Disorder | LPSAustria
-
MetaCure LimitedUnknownType 2 DiabetesAustralia, Austria, Greece, Italy, Poland, Serbia
-
Eli Lilly and CompanyTerminatedDiabetes Mellitus, Type 2Russian Federation, Spain, Germany, Australia, Austria, Israel, Czech Republic
-
Baker Heart Research InstituteUnknownObesity | Metabolic Syndrome | Type 2 DiabetesAustralia
-
QL Biopharmaceutical Australia Pty LtdNovotech (Australia) Pty Limited; Beijing QL Biopharmaceutical Co.,LtdRecruiting
-
Resverlogix CorpNucleus Network Ltd; Baker Heart and Diabetes InstituteCompleted
-
Unilever R&DCommonwealth Scientific and Industrial Research Organisation, AustraliaCompletedVascular Diseases | Diabetes Mellitus | HypercholesterolemiaAustralia
-
Prim. Priv. Doz. Dr. Daniel CejkaMedice Arzneimittel Pütter GmbH & Co KGWithdrawnKidney Transplant; ComplicationsAustria
-
Arrowhead PharmaceuticalsCompletedHypertriglyceridemia | Familial ChylomicronemiaAustralia, Canada, New Zealand
-
Bayside HealthBaker Heart Research Institute; International Diabetes Institute, AustraliaTerminated
-
Glycomine, Inc.Recruiting24-Week Study to Assess the PD, Safety, Tolerability, and PK of GLM101 in Participants With PMM2-CDGPmm2-CDGSpain, Australia, United States
-
St Vincent's Institute of Medical ResearchJuvenile Diabetes Research Foundation; Juvenile Diabetes Research Foundation...Active, not recruiting
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesAustralia
-
Nemysis LtdRDC Clinical Pty LtdRecruitingIron-deficiencyAustralia
-
Menzies Institute for Medical ResearchRecruiting
-
The George InstituteNational Health and Medical Research Council, Australia; University of British... and other collaboratorsCompletedHyperglycemia | Critical IllnessAustralia
-
Kirby InstituteNational Heart, Lung, and Blood Institute (NHLBI); St Vincent's Hospital, Sydney and other collaboratorsCompletedGlucose Metabolism Disorders | Metabolic Diseases | HIV Infections | Cardiovascular Disease | Dyslipidemias | LipodystrophyAustralia
-
Melbourne HealthNational Health and Medical Research Council, Australia; Juvenile Diabetes...Active, not recruitingDiabetes Mellitus, Type 1 | Type 1 DiabetesAustralia
-
Menzies School of Health ResearchWithdrawn
-
Amicus TherapeuticsCompleted
-
Monash UniversityUnknownInsulin SensitivityAustralia
-
Marcus SaemannCompleted
-
St Vincent's Hospital MelbourneJuvenile Diabetes Research Foundation; MedtronicCompletedType 1 DiabetesAustralia
-
GlaxoSmithKlineTerminated
-
Ultragenyx Pharmaceutical IncAbeona Therapeutics, IncEnrolling by invitationMucopolysaccharidosis III-AUnited States, Australia, Spain
-
Austin HealthCompleted
-
SanofiCompleted
-
Silence Therapeutics plcMedpace, Inc.CompletedDyslipidemias | Hyperlipidemias | Elevated Lp(a)United States, Australia, United Kingdom, Netherlands
-
4D Molecular TherapeuticsActive, not recruiting
-
Amicus TherapeuticsCompletedFabry DiseaseAustralia, Brazil
-
Nacuity Pharmaceuticals, Inc.Recruiting
-
Carmot Australia First Pty LtdCarmot Therapeutics, Inc.RecruitingType 2 Diabetes | Overweight or ObesityAustralia
-
Affiris AGMedical University of ViennaCompleted
-
Medical University of GrazCompletedFluvastatin 80 mg Ret. vs Combination With Ezetimibe 10 mg in Patients With High Cardiovascular RiskHypercholesterolemiaAustria
-
Melbourne HealthCompletedType 1 DiabetesAustralia, New Zealand
-
Bayside HealthCompletedObesity | Insulin Resistance | Type 2 DiabetesAustralia
-
Medical University of ViennaCompleted
-
Sciwind Biosciences APAC CO Pty. Ltd.Hangzhou Sciwind Biosciences Co., Ltd.Not yet recruitingObesity | Type 2 Diabetes MellitusAustralia
-
Vaxxinity, Inc.Novotech (Australia) Pty LimitedActive, not recruiting
-
Bristol-Myers SquibbCompletedDyslipidemiaCanada, Australia, United States
-
Monash UniversityNational Health and Medical Research Council, AustraliaActive, not recruitingHeart Failure | Atrial Fibrillation | Hypercholesterolemia | Healthy AgeingAustralia